SARS corona virus peptides recognized by antibodies in the sera of convalescent cases.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 15207612)

Published in Virology on July 01, 2004

Authors

Jian-Ping Guo1, Martin Petric, William Campbell, Patrick L McGeer

Author Affiliations

1: Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.

Articles citing this

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A (2007) 1.76

PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem (2010) 1.62

Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.41

Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. J Biol Chem (2011) 1.22

The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol (2006) 1.09

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol (2005) 1.08

Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis (2006) 1.04

Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. J Virol (2006) 1.04

Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J Virol (2005) 1.03

SARS coronavirus accessory proteins. Virus Res (2007) 1.01

Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opin Biol Ther (2009) 0.98

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. Can J Infect Dis Med Microbiol (2006) 0.95

The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein. Virol J (2005) 0.89

Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol (2014) 0.89

Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein. J Virol (2009) 0.87

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. J Virol (2009) 0.83

The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis. Viruses (2012) 0.83

Characterization of spontaneously generated prion-like conformers in cultured cells. Aging (Albany NY) (2011) 0.81

SARS-CoV 9b protein diffuses into nucleus, undergoes active Crm1 mediated nucleocytoplasmic export and triggers apoptosis when retained in the nucleus. PLoS One (2011) 0.81

Influence of Mabs on PrP(Sc) formation using in vitro and cell-free systems. PLoS One (2012) 0.78

SARS coronavirus 3b accessory protein modulates transcriptional activity of RUNX1b. PLoS One (2012) 0.76

Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein. Proteomics (2010) 0.75

Sensitive and specific enzyme-linked immunosorbent assay using chemiluminescence for detection of severe acute respiratory syndrome viral infection. J Clin Microbiol (2007) 0.75

Articles by these authors

The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68

Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29

Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85

The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology (2008) 3.64

Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis (2004) 2.90

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ (2011) 2.50

GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. Int J Cancer (2010) 2.18

Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2003) 2.04

A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics (2007) 2.03

Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. J Clin Microbiol (2004) 1.81

Inflammation, the complement system and the diseases of aging. Neurobiol Aging (2005) 1.70

Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis (2010) 1.68

PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem (2010) 1.62

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis (2011) 1.61

Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science (2013) 1.61

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis (2012) 1.58

Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol (2008) 1.56

Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med (2005) 1.55

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis (2012) 1.47

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol (2003) 1.47

LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol (2006) 1.46

Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ (2007) 1.43

Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis (2010) 1.43

Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology (2005) 1.41

Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.41

Pediatric Epstein-Barr Virus-Associated Encephalitis: 10-Year Review. J Child Neurol (2006) 1.41

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. J Infect Dis (2004) 1.40

Severe vascular disturbance in a case of familial brain calcinosis. Acta Neuropathol (2005) 1.38

Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol (2007) 1.38

Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries. J Med Virol (2010) 1.36

The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol (2005) 1.29

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia (2007) 1.26

Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis (2008) 1.24

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging (2006) 1.24

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis (2014) 1.23

Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza. J Clin Virol (2009) 1.23

Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. J Biol Chem (2011) 1.22

A web application for moderation training: initial results of a randomized clinical trial. J Subst Abuse Treat (2009) 1.21

Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res (2002) 1.21

Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J Biol Chem (2010) 1.20

Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem Biophys Res Commun (2009) 1.20

Astrocytes are GABAergic cells that modulate microglial activity. Glia (2011) 1.19

Detection of human influenza virus in the stool of children. Pediatr Infect Dis J (2006) 1.19

Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J (2010) 1.18

Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation (2008) 1.18

Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ (2010) 1.18

Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol (2004) 1.18

The college drinker's check-up: outcomes of two randomized clinical trials of a computer-delivered intervention. Psychol Addict Behav (2011) 1.17

Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J (2006) 1.17

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. J Gen Virol (2006) 1.16

Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging (2009) 1.14

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis (2012) 1.14

Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics (2011) 1.12

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol (2007) 1.11

Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res (2009) 1.11

Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2002) 1.10

Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis (2006) 1.10

Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol (2003) 1.10

Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest (2002) 1.09

Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int (2002) 1.09

Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol (2006) 1.09

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. J Gen Virol (2008) 1.07

Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging (2002) 1.06

Overcoming Addictions, a Web-based application, and SMART Recovery, an online and in-person mutual help group for problem drinkers, part 1: three-month outcomes of a randomized controlled trial. J Med Internet Res (2013) 1.05

The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know. Can J Public Health (2009) 1.05

Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis. BioDrugs (2005) 1.05

An extensive phenotypic characterization of the hTNFalpha transgenic mice. BMC Physiol (2007) 1.04

Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis (2006) 1.04

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging (2008) 1.03

Neonatal genital herpes simplex virus type 1 infection after Jewish ritual circumcision: modern medicine and religious tradition. Pediatrics (2004) 1.03

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial. Clin Vaccine Immunol (2011) 1.03

Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim Biophys Acta (2009) 1.01

Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res (2005) 1.01

A simultaneous ERP/fMRI investigation of the P300 aging effect. Neurobiol Aging (2012) 1.01

Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J Biol Chem (2004) 1.00

ModerateDrinking.Com and moderation management: outcomes of a randomized clinical trial with non-dependent problem drinkers. J Consult Clin Psychol (2011) 1.00

Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina (2010) 1.00

Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata. Pediatr Infect Dis J (2011) 1.00

Pediatric Epstein-Barr virus-associated encephalitis: 10-year review. J Child Neurol (2006) 0.99

Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia (2010) 0.99

Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease. Nat Med (2004) 0.98

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine (2006) 0.98

Mechanisms of GABA release from human astrocytes. Glia (2011) 0.96

Expression of complement messenger RNAs and proteins by human oligodendroglial cells. Glia (2003) 0.96

Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health (2011) 0.96

Impaired baseline regional cerebral perfusion in patients referred for coronary artery bypass. J Thorac Cardiovasc Surg (2006) 0.95

Fulminant disseminated Varicella Zoster virus infection without skin involvement. J Clin Virol (2002) 0.95

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. Can J Infect Dis Med Microbiol (2006) 0.95

The complete sequence of the bovine torovirus genome. Virus Res (2005) 0.94

Physician use of a participatory decision-making style with children with ADHD and their parents. Patient Educ Couns (2005) 0.94

The effects of moderate alcohol supplementation on estrone sulfate and DHEAS in postmenopausal women in a controlled feeding study. Nutr J (2004) 0.94

Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant (2005) 0.93

Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging (2008) 0.93

Improving the quality of reporting alcohol outcome studies: effects of the CONSORT statement. Addict Behav (2010) 0.93

Return to physical activity after exertional rhabdomyolysis. Curr Sports Med Rep (2008) 0.93

Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn (2012) 0.92

Headache triggers in the US military. Headache (2009) 0.92